sumatriptan has been researched along with pnu 109291 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ennis, MD; Ghazal, NB; Hall, ED; Harris, LT; Hoffman, RL; Im, WB; Lawson, CF; Lewis, RA; McCall, RB; Pregenzer, JF; Schlachter, SK; Smith, MW; Sutter, DM; Svensson, KA | 1 |
| Choi, SK; Green, D; Ho, A; Klein, U; Marquess, D; Taylor, R; Turner, SD | 1 |
| Elhusseiny, A; Hamel, E | 1 |
| Bhattacharya, A; Cohen, ML; Galbreath, E; Nisenbaum, L; Schenck, KW; Xu, YC | 1 |
| Centurión, D; Gupta, S; Jiménez-Mena, LR; Lozano-Cuenca, J; MaassenVanDenBrink, A; Mehrotra, S; Muñoz-Islas, E; Sánchez-López, A; Villalón, CM | 1 |
5 other study(ies) available for sumatriptan and pnu 109291
| Article | Year |
|---|---|
Isochroman-6-carboxamides as highly selective 5-HT1D agonists: potential new treatment for migraine without cardiovascular side effects.
Topics: Animals; Benzopyrans; Biological Availability; Blood Pressure; Brain; Capillary Permeability; Carotid Arteries; Cats; Cell Line; Drug Evaluation, Preclinical; Dura Mater; Gorilla gorilla; Guinea Pigs; Hypothermia; Inflammation; Migraine Disorders; Piperazines; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Stereoisomerism; Sumatriptan; Vascular Resistance; Vasoconstrictor Agents | 1998 |
Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide.
Topics: Animals; Benzamides; CHO Cells; Cricetinae; Cricetulus; Dimerization; In Vitro Techniques; Indoles; Ligands; Muscle Contraction; Muscle, Smooth, Vascular; Rabbits; Radioligand Assay; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptor, Serotonin, 5-HT1F; Receptors, Serotonin; Saphenous Vein; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists; Structure-Activity Relationship | 2008 |
Sumatriptan elicits both constriction and dilation in human and bovine brain intracortical arterioles.
Topics: Animals; Arterioles; Benzopyrans; Carbazoles; Cattle; Cerebral Cortex; Cerebrovascular Circulation; Enzyme Inhibitors; Fluorobenzenes; Humans; Muscle Tonus; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Piperazines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents; Vasodilator Agents | 2001 |
5-Hydroxytryptamine1B receptor-mediated contraction of rabbit saphenous vein and basilar artery: role of vascular endothelium.
Topics: Animals; Antigens, CD34; Basilar Artery; Benzopyrans; Binding Sites; Endothelium, Vascular; NG-Nitroarginine Methyl Ester; Piperazines; Rabbits; Receptor, Serotonin, 5-HT1B; Saphenous Vein; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Vasoconstriction; Vasoconstrictor Agents | 2004 |
Donitriptan, but not sumatriptan, inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors.
Topics: Acetylcholine; Animals; Benzopyrans; Calcitonin Gene-Related Peptide; Capsaicin; Carotid Artery, External; Chromans; Dogs; Dose-Response Relationship, Drug; Hemodynamics; Humans; In Vitro Techniques; Infusions, Intravenous; Nitriles; Phenylephrine; Piperazines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Vasoconstrictor Agents; Vasodilation | 2006 |